Shandong Buchang Pharmaceuticals Co Ltd (603858) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, Shandong Buchang Pharmaceuticals Co Ltd (603858) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-145.26 Million ≈ $-21.26 Million USD) by net assets (CN¥10.07 Billion ≈ $1.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shandong Buchang Pharmaceuticals Co Ltd (603858) balance sheet quality index to measure how much of total assets are equity-financed.

Shandong Buchang Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Shandong Buchang Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Shandong Buchang Pharmaceuticals Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shandong Buchang Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Buchang Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Advanced Technology & Materials Co Ltd SHE:000969	0.044x
Klaviyo, Inc. NYSE:KVYO	0.078x
Nektar Therapeutics NASDAQ:NKTR	-0.077x
Qinhuangdao Port Co Ltd SHG:601326	0.027x
Capital Securities Corp TW:6005	-0.134x
Inv La Constru SN:ILC	-0.023x
NBTM New Materials Group Co Ltd SHG:600114	0.081x
Nantong Haixing Electronics Co Ltd SHG:603115	0.000x

Annual Cash Flow Conversion Efficiency for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 603858 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥9.81 Billion ≈ $1.44 Billion	CN¥939.95 Million ≈ $137.54 Million	0.096x	+763.71%
2023-12-31	CN¥11.38 Billion ≈ $1.66 Billion	CN¥-164.26 Million ≈ $-24.04 Million	-0.014x	-106.43%
2022-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥2.76 Billion ≈ $403.23 Million	0.224x	+145.65%
2021-12-31	CN¥14.45 Billion ≈ $2.11 Billion	CN¥1.32 Billion ≈ $193.23 Million	0.091x	-35.57%
2020-12-31	CN¥13.81 Billion ≈ $2.02 Billion	CN¥1.96 Billion ≈ $286.63 Million	0.142x	-25.40%
2019-12-31	CN¥13.79 Billion ≈ $2.02 Billion	CN¥2.62 Billion ≈ $383.58 Million	0.190x	+28.47%
2018-12-31	CN¥13.86 Billion ≈ $2.03 Billion	CN¥2.05 Billion ≈ $300.10 Million	0.148x	-0.30%
2017-12-31	CN¥13.22 Billion ≈ $1.93 Billion	CN¥1.96 Billion ≈ $287.10 Million	0.148x	+13.09%
2016-12-31	CN¥12.71 Billion ≈ $1.86 Billion	CN¥1.67 Billion ≈ $244.20 Million	0.131x	-55.07%
2015-12-31	CN¥7.26 Billion ≈ $1.06 Billion	CN¥2.12 Billion ≈ $310.33 Million	0.292x	-27.01%
2014-12-31	CN¥4.45 Billion ≈ $651.08 Million	CN¥1.78 Billion ≈ $260.56 Million	0.400x	+53.90%
2013-12-31	CN¥4.28 Billion ≈ $626.87 Million	CN¥1.11 Billion ≈ $163.01 Million	0.260x	-22.48%
2012-12-31	CN¥4.02 Billion ≈ $588.56 Million	CN¥1.35 Billion ≈ $197.43 Million	0.335x	-39.43%
2011-12-31	CN¥2.80 Billion ≈ $409.96 Million	CN¥1.55 Billion ≈ $227.05 Million	0.554x	--

About Shandong Buchang Pharmaceuticals Co Ltd

SHG:603858 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.38 Billion

CN¥16.28 Billion CNY

Market Cap Rank

#5515 Global

#958 in China

Share Price

CN¥15.44

Change (1 day)

-2.28%

52-Week Range

CN¥14.37 - CN¥20.02

All Time High

CN¥62.04